If you need a more accessible version of this website, click this button on the right. Switch to Accessible Site


You are using an outdated browser. Please upgrade your browser to improve your experience.

Close [x]

Follow Us


CADI IL-31 immunotherapy

Cytopoint®, formally known as Canine Atopic Dermatitis Immunotherapeutic (CADI), is a sterile caninized anti-IL-31 monoclonal antibody injection. It interrupts the cycle of itch and inflammation in dogs with atopic dermatitis by targeting the IL-31 pathway.

  • The injection starts to reduce itchiness within a day, successful itch reduction by day 3, and generally lasts for a full month (in some patients may last 2 months).
  • Cytopoint® is a biological therapy. It is not a drug, and therefore is broken down and recycled by the body naturally.
  • Cytopoint® remains in circulation for several weeks.
  • Safe to give dogs of all ages.
  • This is not a steroid or immunosuppressant.
  • Given subcutaneously in accordance to body weight.
  • No contraindictions with other medications including parasiticides, antibiotics, antifungals, corticosteroids, vaccines, immunotherapy, antihistamines, or  immunosuppressive antipruritic medications (Apoquell®​  or cyclosporine).
  • Side effects are uncommon but may include vomiting, diarrhea and/or lethargy.

For more information visit www.cytopoint4dogs.com

  • Itch tracker:

For a downloadable itch tracker visit: http://www.cytopoint4dogs.com/img/others/cytopoint_petowneritchtracker.pdf